NANOMEDICINES FOR TARGETED CANCER TREATMENT


Arrogene’s team of scientists has developed a family of related bio-polymer based nano agents that are capable of crossing the blood-brain-barrier. Polyolefin™ is a new drug delivery system can both identify cancer cell types through “virtual biopsies,” as well as target the molecular backbone of cancer.